These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25158104)

  • 21. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
    Tabbara RI; Fletcher PJ
    Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological Modulation of 5-HT
    Browne CJ; Ji X; Higgins GA; Fletcher PJ; Harvey-Lewis C
    Neuropsychopharmacology; 2017 Oct; 42(11):2178-2187. PubMed ID: 28720903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Fletcher PJ; Sinyard J; Higgins GA
    Pharmacol Biochem Behav; 2010 Nov; 97(1):170-8. PubMed ID: 20624416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats.
    Liu X; Jernigen C; Gharib M; Booth S; Caggiula AR; Sved AF
    Behav Pharmacol; 2010 Mar; 21(2):153-60. PubMed ID: 20168211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects.
    Satanove DJ; Rahman S; Chan TMV; Ren S; Clarke PBS
    Psychopharmacology (Berl); 2021 Feb; 238(2):475-486. PubMed ID: 33150479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD; Higgins GA; Fletcher PJ
    ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.
    Fletcher PJ; Rizos Z; Noble K; Higgins GA
    Neuropharmacology; 2011 Sep; 61(3):468-77. PubMed ID: 21402085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ; Mosher TM; Greenshaw AJ
    Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
    Agnoli L; Carli M
    Psychopharmacology (Berl); 2012 Jan; 219(2):633-45. PubMed ID: 22113450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion.
    Barrett ST; Geary TN; Steiner AN; Bevins RA
    Psychopharmacology (Berl); 2017 Jan; 234(2):187-198. PubMed ID: 27695921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine receptor antagonism and amphetamine-induced psychomotor sensitization on sign- and goal-tracking after extended training.
    Khoo SY; Uhrig A; Samaha AN; Chaudhri N
    Behav Brain Res; 2021 Jun; 407():113238. PubMed ID: 33744334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta2-Subunit-containing nicotinic acetylcholine receptors are involved in nicotine-induced increases in conditioned reinforcement but not progressive ratio responding for food in C57BL/6 mice.
    Brunzell DH; Chang JR; Schneider B; Olausson P; Taylor JR; Picciotto MR
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):328-38. PubMed ID: 16133126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors.
    Guy EG; Fletcher PJ
    Psychopharmacology (Berl); 2013 Jan; 225(2):429-40. PubMed ID: 22885874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E; Carli M; Baviera M; Invernizzi RW
    J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking serotonin 2A (5-HT
    Madden JT; Reyna NC; Goranson EV; Gonzalez TA; Zavala AR; Pentkowski NS
    Behav Brain Res; 2021 Oct; 415():113521. PubMed ID: 34391796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.